Cochrane Abstracts
Chimeric antigen receptor (CAR) T‐cell therapy for people with relapsed or refractory diffuse large B‐cell lymphoma New
Chimeric antigen receptor (CAR) T‐cell therapy for people with relapsed or refractory diffuse large B‐cell lymphoma New is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Chimeric Antigen Receptor (CAR) T‐cell Therapy for People With Relapsed or Refractory Diffuse Large B‐cell Lymphoma New." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431170/all/Chimeric_antigen_receptor__CAR__T���������cell_therapy_for_people_with_relapsed_or_refractory_diffuse_large_B���������cell_lymphoma_New. Accessed 22 March 2023.
Chimeric antigen receptor (CAR) T‐cell therapy for people with relapsed or refractory diffuse large B‐cell lymphoma New. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431170/all/Chimeric_antigen_receptor__CAR__T���������cell_therapy_for_people_with_relapsed_or_refractory_diffuse_large_B���������cell_lymphoma_New. Accessed March 22, 2023.
Chimeric antigen receptor (CAR) T‐cell therapy for people with relapsed or refractory diffuse large B‐cell lymphoma New. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431170/all/Chimeric_antigen_receptor__CAR__T���������cell_therapy_for_people_with_relapsed_or_refractory_diffuse_large_B���������cell_lymphoma_New
Chimeric Antigen Receptor (CAR) T‐cell Therapy for People With Relapsed or Refractory Diffuse Large B‐cell Lymphoma New [Internet]. In: Cochrane Abstracts. [cited 2023 March 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431170/all/Chimeric_antigen_receptor__CAR__T���������cell_therapy_for_people_with_relapsed_or_refractory_diffuse_large_B���������cell_lymphoma_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Chimeric antigen receptor (CAR) T‐cell therapy for people with relapsed or refractory diffuse large B‐cell lymphoma New
ID - 431170
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431170/all/Chimeric_antigen_receptor__CAR__T���������cell_therapy_for_people_with_relapsed_or_refractory_diffuse_large_B���������cell_lymphoma_New
DB - Evidence Central
DP - Unbound Medicine
ER -
